Home
/
BIOLARGO, INC.
/
Financials
/
Quarterly
BIOLARGO, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that BIOLARGO, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2017
Mar 31, 2017
$46.0K
May 17, 2017
Q3
2016
Sep 30, 2016
$215.2K
Nov 14, 2016
Q2
2016
Jun 30, 2016
$52.9K
Aug 15, 2016
Q1
2016
Mar 31, 2016
$13.9K
May 16, 2016
Q3
2015
Sep 30, 2015
$72.8K
Nov 16, 2015
Q2
2015
Jun 30, 2015
$39.8K
Aug 10, 2015
Q1
2015
Mar 31, 2015
$26.7K
May 15, 2015
Q3
2014
Sep 30, 2014
$16.4K
Nov 14, 2014
Q2
2015
Jun 30, 2014
$21.1K
Aug 10, 2015
Q1
2015
Mar 31, 2014
$9.3K
May 15, 2015
Q3
2014
Sep 30, 2013
$18.4K
Nov 14, 2014
Q2
2014
Jun 30, 2013
$120.0K
Aug 15, 2014
Q1
2014
Mar 31, 2013
$14.4K
May 15, 2014
Q3
2012
Sep 30, 2012
$10.5K
Nov 14, 2012
Q2
2012
Jun 30, 2012
$13.8K
Aug 14, 2012
Q1
2013
Mar 31, 2012
$30.8K
May 15, 2013
Q3
2012
Sep 30, 2011
$120.5K
Nov 14, 2012
Q2
2012
Jun 30, 2011
$12.2K
Aug 14, 2012
Q1
2012
Mar 31, 2011
$9.5K
May 15, 2012
Q3
2011
Sep 30, 2010
$42.8K
Nov 15, 2011
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2017
Sep 30, 2017
$172.0K
Nov 14, 2017
Q2
2017
Jun 30, 2017
$100.0K
Aug 14, 2017
Q1
2017
Mar 31, 2017
$46.0K
May 17, 2017
Q3
2017
Sep 30, 2016
$162.3K
Nov 14, 2017
Q2
2017
Jun 30, 2016
$39.0K
Aug 14, 2017
Q1
2017
Mar 31, 2016
$13.9K
May 17, 2017
Q3
2016
Sep 30, 2015
$43.3K
Nov 14, 2016
Q3
2013
Sep 30, 2013
$18.4K
Nov 13, 2013
Q2
2013
Jun 30, 2013
$120.0K
Aug 14, 2013
Q3
2013
Sep 30, 2012
$10.5K
Nov 13, 2013
Q2
2013
Jun 30, 2012
$13.8K
Aug 14, 2013
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2015
Sep 30, 2015
($3.80M)
Nov 16, 2015
Q3
2015
Jun 30, 2015
($1.82M)
Nov 16, 2015
Q2
2015
Jun 30, 2015
($1.29M)
Aug 10, 2015
Q1
2015
Mar 31, 2015
($780.4K)
May 15, 2015
Q3
2014
Sep 30, 2014
($826.5K)
Nov 14, 2014
Q2
2015
Jun 30, 2014
($1.06M)
Aug 10, 2015
Q3
2015
Jun 30, 2014
($826.5K)
Nov 16, 2015
Q1
2015
Mar 31, 2014
($1.02M)
May 15, 2015
Q3
2014
Sep 30, 2013
($780.2K)
Nov 14, 2014
Q2
2014
Jun 30, 2013
($538.8K)
Aug 15, 2014
Q1
2013
Mar 31, 2013
($645.3K)
May 15, 2013
Q3
2013
Sep 30, 2012
($915.7K)
Nov 13, 2013
Q2
2013
Jun 30, 2012
($1.78M)
Aug 14, 2013
Q1
2013
Mar 31, 2012
($921.0K)
May 15, 2013
Q3
2012
Sep 30, 2011
($711.7K)
Nov 14, 2012
Q2
2012
Jun 30, 2011
($892.1K)
Aug 14, 2012
Q1
2012
Mar 31, 2011
($1.44M)
May 15, 2012
Q3
2011
Sep 30, 2010
($1.17M)
Nov 15, 2011
Q2
2011
Jun 30, 2010
($1.29M)
Aug 17, 2011
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($7.18M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($1.80M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($1.86M)
May 15, 2025
Q3
2025
Sep 30, 2024
($1.06M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($890.0K)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($763.0K)
May 15, 2025
Q3
2024
Sep 30, 2023
($1.54M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($1.56M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($477.0K)
May 14, 2024
Q3
2023
Sep 30, 2022
($943.0K)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($1.32M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($1.71M)
May 17, 2023
Q3
2022
Sep 30, 2021
($1.46M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($1.70M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($1.86M)
May 16, 2022
Q3
2021
Sep 30, 2020
($1.91M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($2.01M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($1.70M)
May 17, 2021
Q3
2020
Sep 30, 2019
($1.88M)
Nov 16, 2020
Q2
2020
Jun 30, 2019
($1.49M)
Aug 14, 2020